Publication #5366
Reference
Name
Levonorgestrol and ulipristal remain suitable emergency contraceptives for all women regardless of bodyweight
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
CONTRACEPTION
ORAL CONTRACEPTIVES
WOMEN
WEIGHT
OBESITY
Description
Attaches a letter from the Medicines and Healthcare products Regulatory Agency regarding the outcome of the recent European review on the effectiveness of emergency contraceptives containing levonorgestrel or ulipristal acetate.
Contact Name
Irene Fazakerley
Contact Address
Pharmacy and Medicines Division, Finance, e-Health and Pharmaceuticals Directorate, St Andrew's House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone
Created
2014-07-24 00:00:00
Click to go back to homepage